Morris Epstein
Family Medicine · Plantation, FLNPI 1114982071
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations.
Across 105 payments — averaging $23.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$482
- Sanofi-aventis U.S. LLC$414
- Johnson & Johnson$393
- Amarin Pharma, Inc.$369
- AstraZeneca$153
- Lilly USA, LLC$110
- plus $534 from 15 others
What the payments were for
- Food & beverage$2,42099%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $482 |
| Sanofi-aventis U.S. LLC | 13 | $414 |
| Johnson & Johnson | 16 | $393 |
| Amarin Pharma, Inc. | 14 | $369 |
| AstraZeneca | 8 | $153 |
| Lilly USA, LLC | 4 | $110 |
| Kowa Pharmaceuticals America, Inc. | 4 | $92 |
| Pfizer | 5 | $91 |
| AbbVie(2 entities) | 5 | $91 |
| Amgen | 4 | $67 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Bristol Myers Squibb | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Novartis | 1 | $11 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,454 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 81 | $1,055 |
| Ezetimibe | 38 | $949 |
| Losartan Potassium | 39 | $450 |
| Atorvastatin Calcium | 42 | $359 |
| Famotidine | 11 | $295 |
| Levothyroxine Sodium | 26 | $250 |
| Metoprolol Succinate | 11 | $135 |
| Metformin Hcl | 16 | $106 |
| Amlodipine Besylate | 25 | $90 |
| Simvastatin | 12 | $89 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Plantation
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.